Becton Dickinson Vitals Drop: Analysts ‘Have Been Wrong’ On This Med Tech Stock For Years

Becton Dickinson receives multiple downgrades as analysts cite weakening organic growth and trimmed price targets following a Q2 update. Latest Ratings for BDX Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 SVB Leerink Maintains Market Perform Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for BDX View the…

Read More

No Quick Fix for Kohl’s: Analyst Highlights Challenges Despite Leadership Change

Telsey analyst lowers price forecast for Kohl’s Corp. after CEO termination and preliminary Q1 results, citing challenges in regaining consumer trust. Latest Ratings for KSS Date Firm Action From To Mar 2022 Telsey Advisory Group Maintains Market Perform Mar 2022 Credit Suisse Maintains Neutral Feb 2022 Gordon Haskett Downgrades Buy Accumulate View More Analyst Ratings…

Read More